Apotheek Browaeys: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Apotheek Browaeys
Largest movements
- Current investments +€50,000
new in 2025: €50,000
- Cash -€37,899
down €37,899 (-18.9%), from €200,750 to €162,851
mainly Current investments (-€50,000) and Trade debts (-€28,927)
- Receivables within one year -€31,541
down €31,541 (-23.0%), from €137,178 to €105,637
of which Trade receivables: -€16,952
- Tangible fixed assets -€15,178
down €15,178 (-25.4%), from €59,716 to €44,538
of which Land and buildings: -€11,283
- Reserves +€31,880
up €31,880 (+8.4%), from €379,944 to €411,824
of which Distributable reserves: +€31,880
- Trade debts -€28,927
down €28,927 (-33.6%), from €86,170 to €57,244
- Other debts -€16,175
down €16,175 (-29.7%), from €54,492 to €38,318
- Short-term financial debts -€15,077
no longer reported in 2025 (was €15,077)
- Gross operating margin -€19,760
down €19,760 (-12.2%), from €161,857 to €142,097
- Taxes -€5,356
down €5,356 (-29.3%), from €18,304 to €12,949
- Staff costs +€2,208
up €2,208 (+3.1%), from €72,307 to €74,515
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €573,121 | €541,697 | -€31,424 | -5.5% |
| Fixed assets | 21/28 | €59,716 | €44,538 | -€15,178 | -25.4% |
| Tangible fixed assets | 22/27 | €59,716 | €44,538 | -€15,178 | -25.4% |
| Land and buildings | 22 | €53,239 | €41,956 | -€11,283 | -21.2% |
| Plant, machinery and equipment | 23 | €2,139 | €1,565 | -€574 | -26.8% |
| Furniture and vehicles | 24 | €4,337 | €1,016 | -€3,321 | -76.6% |
| Current assets | 29/58 | €513,405 | €497,159 | -€16,247 | -3.2% |
| Stocks and contracts in progress | 3 | €165,982 | €168,992 | +€3,010 | +1.8% |
| Stocks | 30/36 | €165,982 | €168,992 | +€3,010 | +1.8% |
| Amounts receivable within one year | 40/41 | €137,178 | €105,637 | -€31,541 | -23.0% |
| Trade receivables | 40 | €115,446 | €98,494 | -€16,952 | -14.7% |
| Other amounts receivable | 41 | €21,732 | €7,143 | -€14,589 | -67.1% |
| Current investments | 50/53 | - | €50,000 | +€50,000 | |
| Cash at bank and in hand | 54/58 | €200,750 | €162,851 | -€37,899 | -18.9% |
| Deferred charges and accrued income | 490/1 | €9,496 | €9,679 | +€183 | +1.9% |
| Total equity and liabilities | 10/49 | €573,121 | €541,697 | -€31,424 | -5.5% |
| Equity | 10/15 | €399,944 | €431,824 | +€31,880 | +8.0% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €379,944 | €411,824 | +€31,880 | +8.4% |
| Tax-exempt reserves | 132 | €1,383 | €1,383 | = | 0.0% |
| Distributable reserves | 133 | €378,562 | €410,442 | +€31,880 | +8.4% |
| Amounts payable | 17/49 | €173,177 | €109,872 | -€63,304 | -36.6% |
| Amounts payable within one year | 42/48 | €173,177 | €109,872 | -€63,304 | -36.6% |
| Financial debts | 43 | €15,077 | - | -€15,077 | |
| Credit institutions | 430/8 | €15,077 | - | -€15,077 | |
| Trade debts | 44 | €86,170 | €57,244 | -€28,927 | -33.6% |
| Suppliers | 440/4 | €86,170 | €57,244 | -€28,927 | -33.6% |
| Taxes, remuneration and social security | 45 | €17,437 | €14,311 | -€3,127 | -17.9% |
| Taxes | 450/3 | €1,362 | €872 | -€490 | -36.0% |
| Remuneration and social security | 454/9 | €16,076 | €13,439 | -€2,637 | -16.4% |
| Other amounts payable | 47/48 | €54,492 | €38,318 | -€16,175 | -29.7% |
| Remuneration, social security and pensions | 62 | €72,307 | €74,515 | +€2,208 | +3.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €15,942 | €15,178 | -€765 | -4.8% |
| Other operating charges | 640/8 | €1,459 | €973 | -€486 | -33.3% |
| Gross operating margin | 9900 | €161,857 | €142,097 | -€19,760 | -12.2% |
| Operating profit (loss) | 9901 | €72,148 | €51,431 | -€20,718 | -28.7% |
| Financial income | 75/76B | €1,586 | €1,569 | -€17 | -1.1% |
| Recurring financial income | 75 | €1,586 | €1,569 | -€17 | -1.1% |
| Financial charges | 65/66B | €9,665 | €8,171 | -€1,494 | -15.5% |
| Recurring financial charges | 65 | €9,665 | €8,171 | -€1,494 | -15.5% |
| Profit (loss) for the period before taxes | 9903 | €64,069 | €44,829 | -€19,240 | -30.0% |
| Income taxes | 67/77 | €18,304 | €12,949 | -€5,356 | -29.3% |
| Profit (loss) for the period | 9904 | €45,765 | €31,880 | -€13,885 | -30.3% |
| Profit (loss) for the period to be appropriated | 9905 | €45,765 | €31,880 | -€13,885 | -30.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.